ArticleESMO open2026

Impact and effective management of nausea/vomiting on patients treated with zolbetuximab + chemotherapy: insights from the phase III SPOTLIGHT and GLOW studies.

K Shitara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.